eLife (Sep 2020)
Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir
- Jason Neidleman,
- Xiaoyu Luo,
- Julie Frouard,
- Guorui Xie,
- Feng Hsiao,
- Tongcui Ma,
- Vincent Morcilla,
- Ashley Lee,
- Sushama Telwatte,
- Reuben Thomas,
- Whitney Tamaki,
- Benjamin Wheeler,
- Rebecca Hoh,
- Ma Somsouk,
- Poonam Vohra,
- Jeffrey Milush,
- Katherine Sholtis James,
- Nancie M Archin,
- Peter W Hunt,
- Steven G Deeks,
- Steven A Yukl,
- Sarah Palmer,
- Warner C Greene,
- Nadia R Roan
Affiliations
- Jason Neidleman
- Gladstone Institutes, San Francisco, United States; Department of Urology, University of California, San Francisco, San Francisco, United States
- Xiaoyu Luo
- Gladstone Institutes, San Francisco, United States
- Julie Frouard
- Gladstone Institutes, San Francisco, United States; Department of Urology, University of California, San Francisco, San Francisco, United States
- Guorui Xie
- Gladstone Institutes, San Francisco, United States; Department of Urology, University of California, San Francisco, San Francisco, United States
- Feng Hsiao
- Gladstone Institutes, San Francisco, United States; Department of Urology, University of California, San Francisco, San Francisco, United States
- Tongcui Ma
- Gladstone Institutes, San Francisco, United States; Department of Urology, University of California, San Francisco, San Francisco, United States
- Vincent Morcilla
- ORCiD
- Centre for Virus Research, the Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia
- Ashley Lee
- Centre for Virus Research, the Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia
- Sushama Telwatte
- San Francisco Veterans Affairs (VA) Medical Center and University of California, San Francisco, San Francisco, United States
- Reuben Thomas
- Gladstone Institutes, San Francisco, United States
- Whitney Tamaki
- Department of Medicine, University of California, San Francisco, San Francisco, United States
- Benjamin Wheeler
- ORCiD
- Department of Medicine, University of California, San Francisco, San Francisco, United States
- Rebecca Hoh
- Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, San Francisco, United States
- Ma Somsouk
- Department of Medicine, Division of Gastroenterology, San Francisco General Hospital and University of California, San Francisco, San Francisco, United States
- Poonam Vohra
- Department of Pathology, University of California, San Francisco, San Francisco, United States
- Jeffrey Milush
- Department of Medicine, University of California, San Francisco, San Francisco, United States
- Katherine Sholtis James
- Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, United States
- Nancie M Archin
- Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, United States
- Peter W Hunt
- Division of Experimental Medicine, University of California, San Francisco, San Francisco, United States
- Steven G Deeks
- ORCiD
- Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, San Francisco, United States
- Steven A Yukl
- San Francisco Veterans Affairs (VA) Medical Center and University of California, San Francisco, San Francisco, United States
- Sarah Palmer
- Centre for Virus Research, the Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia
- Warner C Greene
- Gladstone Institutes, San Francisco, United States; Department of Medicine, University of California, San Francisco, San Francisco, United States
- Nadia R Roan
- ORCiD
- Gladstone Institutes, San Francisco, United States; Department of Urology, University of California, San Francisco, San Francisco, United States
- DOI
- https://doi.org/10.7554/eLife.60933
- Journal volume & issue
-
Vol. 9
Abstract
The latent reservoir is a major barrier to HIV cure. As latently infected cells cannot be phenotyped directly, the features of the in vivo reservoir have remained elusive. Here, we describe a method that leverages high-dimensional phenotyping using CyTOF to trace latently infected cells reactivated ex vivo to their original pre-activation states. Our results suggest that, contrary to common assumptions, the reservoir is not randomly distributed among cell subsets, and is remarkably conserved between individuals. However, reservoir composition differs between tissues and blood, as do cells successfully reactivated by different latency reversing agents. By selecting 8–10 of our 39 original CyTOF markers, we were able to isolate highly purified populations of unstimulated in vivo latent cells. These purified populations were highly enriched for replication-competent and intact provirus, transcribed HIV, and displayed clonal expansion. The ability to isolate unstimulated latent cells from infected individuals enables previously impossible studies on HIV persistence.
Keywords